StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson gross margin

Gross margin is gross profit as a percentage of revenue.

Johnson & Johnson's gross margin for the twelve months ending Sep 27, 2026 was 67.6%. For fiscal 2025 it was 67.9%, against 69.1% the year before. The highest annual figure on record is 71.0% in fiscal 2008.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 28, 202567.9%−1.2
FY2024Dec 29, 202469.1%+0.3
FY2023Dec 31, 202368.8%−0.4
FY2022Jan 1, 202369.3%−1.0
FY2021Jan 2, 202270.3%+4.7
FY2020Jan 3, 202165.6%−0.8
FY2019Dec 29, 201966.4%−0.4
FY2018Dec 30, 201866.8%+0.1
FY2017Dec 31, 201766.7%−3.0
FY2016Jan 1, 201769.7%+0.4
FY2015Jan 3, 201669.3%−0.1
FY2014Dec 28, 201469.4%+0.7
FY2013Dec 29, 201368.7%+0.9
FY2012Dec 30, 201267.8%−0.9
FY2011Jan 1, 201268.7%−0.8
FY2010Jan 2, 201169.5%−0.7
FY2009Jan 3, 201070.2%−0.8
FY2008Dec 28, 200871.0%+0.0
FY2007Dec 30, 200770.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 27, 202668.1%−1.4
Q2 FY2026Jun 28, 202668.2%+0.3
Q1 FY2026Mar 29, 202666.3%−0.1
Q4 FY2025Dec 28, 202567.6%−0.8
Q3 FY2025Sep 28, 202569.6%+0.5
Q2 FY2025Jun 29, 202567.9%−1.5
Q1 FY2025Mar 30, 202566.4%−3.2
Q4 FY2024Dec 29, 202468.3%+0.1
Q3 FY2024Sep 29, 202469.0%−0.0
Q2 FY2024Jun 30, 202469.4%−0.6
Q1 FY2024Mar 31, 202469.6%+1.6
Q4 FY2023Dec 31, 202368.2%−1.3
Q3 FY2023Oct 1, 202369.1%−0.1
Q2 FY2023Jul 2, 202370.0%+1.2
Q1 FY2023Apr 2, 202368.0%−1.7
Q4 FY2022Jan 1, 202369.5%−15.1
Q3 FY2022Oct 2, 202269.1%+0.2
Q2 FY2022Jul 3, 202268.7%+1.3
Q1 FY2022Apr 3, 202269.7%+1.3
Q4 FY2021Jan 2, 202284.6%+19.4
Q3 FY2021Oct 3, 202168.9%+2.0
Q2 FY2021Jul 4, 202167.5%+3.3
Q1 FY2021Apr 4, 202168.4%+2.5
Q4 FY2020Jan 3, 202165.2%−0.4
Q3 FY2020Sep 27, 202066.9%+0.1
Q2 FY2020Jun 28, 202064.1%−2.1
Q1 FY2020Mar 29, 202065.9%−1.1
Q4 FY2019Dec 29, 201965.6%−0.3
Q3 FY2019Sep 29, 201966.9%−0.7
Q2 FY2019Jun 30, 201966.2%−0.5
Q1 FY2019Mar 31, 201967.0%+0.0
Q4 FY2018Dec 30, 201865.9%+1.8
Q3 FY2018Sep 30, 201867.6%+2.9
Q2 FY2018Jul 1, 201866.7%−2.2
Q1 FY2018Apr 1, 201866.9%−2.6
Q4 FY2017Dec 31, 201764.1%−5.4
Q3 FY2017Oct 1, 201764.8%–
Q2 FY2017Jul 2, 201769.0%–
Q1 FY2017Apr 2, 201769.6%–
Q4 FY2016Jan 1, 201769.4%–

More Johnson & Johnson figures

See a number that looks wrong?